Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The objective will be to assess clinical bioequivalence of 0.1% Retin-A Micro® Gel and Spear
Pharmaceutical's generic 0.1% Tretinoin Microsphere Gel with a placebo arm.